Suppr超能文献

遗传性血管性水肿致 C1 抑制剂缺乏症 1 例,初始症状发生 40 年后出现反复腹痛。

A case of hereditary angioedema due to C1-inhibitor deficiency with recurrent abdominal pain diagnosed 40 years after the occurrence of the initial symptom.

机构信息

Department of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.

Nephrology Unit, Internal Medicine, Saiyu Soka Hospital, 1-7-22 Matsubara, Soka, Saitama, 340-0041, Japan.

出版信息

Clin J Gastroenterol. 2021 Aug;14(4):1175-1179. doi: 10.1007/s12328-021-01338-1. Epub 2021 Feb 5.

Abstract

Hereditary angioedema due to C1-inhibitor deficiency (HAE-C1-INH) is a rare disease, which induces an acute attack of angioedema mediated by bradykinin. HAE-C1-INH can cause serious abdominal pain when severe edema develops in the gastrointestinal tract. However, because it takes a long time, 13.8 years on average in Japan, from the occurrence of the initial symptom to the diagnosis due to low awareness of the disease, undiagnosed HAE-C1-INH patients sometimes undergo unnecessary surgical procedures for severe abdominal pain. We herein present a 56-year-old patient with HAE-C1-INH, who underwent numerous abdominal operations. He frequently needed hospitalization with the administration of opioid due to severe abdominal pain. However, after he was accurately diagnosed with HAE-C1-INH at 55 years of age, he could start self-administration for an acute attack with icatibant, a selective bradykinin B2 receptor antagonist. Consequently, he did not need hospitalizing for ten months after the beginning of the treatment. A series of an accurate diagnosis and appropriate treatment for HAE-C1-INH improved his quality of life. Thus, HAE-C1-INH should be considered, when we meet patients with unidentified recurrent abdominal pain. This case highlights significance of an early diagnosis and appropriate treatment for HAE-C1-INH.

摘要

遗传性血管性水肿伴 C1 酯酶抑制剂缺乏症(HAE-C1-INH)是一种罕见疾病,由缓激肽介导导致急性血管性水肿发作。当胃肠道严重水肿时,HAE-C1-INH 可引起严重腹痛。然而,由于对该病的认识不足,从最初症状发生到确诊平均需要 13.8 年的时间,因此未确诊的 HAE-C1-INH 患者有时会因严重腹痛而接受不必要的手术。本文报告了一位 56 岁 HAE-C1-INH 患者,他接受了多次腹部手术。由于严重腹痛,他经常需要住院并使用阿片类药物。然而,在他 55 岁时被准确诊断为 HAE-C1-INH 后,他可以开始使用依替巴肽(一种选择性缓激肽 B2 受体拮抗剂)进行急性发作的自我治疗。因此,在开始治疗后的十个月内,他无需住院。一系列准确的诊断和适当的治疗改善了他的生活质量。因此,当我们遇到不明原因的复发性腹痛患者时,应考虑 HAE-C1-INH。本病例强调了早期诊断和适当治疗 HAE-C1-INH 的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb68/8298325/9f9e8f52f1ce/12328_2021_1338_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验